Serum Institute puts India trials of AstraZeneca's Covid-19 vaccine on hold


MUMBAI (Reuters) - Serum Institute of India has put trials of AstraZeneca's COVID-19 vaccine candidate on hold until the British drugmaker restarts the trials, Serum said on Thursday. "We are reviewing the situation and pausing India trials," Serum said in a brief statement.

AstraZeneca said on Tuesday it had paused trials of its experimental coronavirus vaccine because of an unexplained illness in a study participant, but its partner Serum had at the time said its trials in India were still ongoing.   (Reporting.

This article is no longer available in our repository.

There could be multiple reasons for this.